Atomera Inc. reported fourth‑quarter 2025 results that included a net loss of $4.4 million, or $0.14 per share, and revenue of $50,000—half of the $100,000 consensus estimate. The company’s earnings per share matched analyst expectations, but the revenue miss underscored the continued difficulty of translating its technology into commercial sales.
The quarter’s $4.4 million loss is part of a broader trend: the full‑year 2025 net loss rose to $20.2 million from $18.4 million in FY 2024, while the third‑quarter loss was $5.6 million. Research and development expenses climbed to $12.3 million, up from $11.0 million in FY 2024, contributing to margin compression and the widening annual loss.
Revenue for the quarter and the year fell sharply. Q4 revenue of $50,000 was 50% below expectations, and full‑year revenue of $65,000 dropped from $135,000 in FY 2024. The company’s income was driven almost entirely by non‑recurring engineering (NRE) fees for wafer deliveries and licensing of its Mears Silicon Technology (MST) software, with no significant commercial sales reported. The lack of recurring revenue highlights the early‑stage nature of Atomera’s business model.
Cash and cash equivalents stood at $20.3 million as of September 30 2025. With a cash burn of $15 million over the last year, the company’s runway is estimated at 16–17 months. CFO Francis Laurencio noted that cash at year‑end 2025 was $19.2 million, down from $26.7 million in FY 2024, indicating a need for additional funding to sustain operations.
Management emphasized both progress and caution. CEO Scott Bibaud highlighted “inspiring” results from MST for gate‑all‑around transistors and ongoing wafer runs with a top‑20 semiconductor customer. CFO Laurencio explained that revenue was largely NRE and licensing, and that the company’s cash position would support operations for the next 16–17 months. Guidance for Q1 2026 revenue remains in the $50,000–$100,000 range, unchanged from prior guidance.
Investors reacted to the revenue miss, which was the primary driver of the initial negative sentiment. The fact that earnings per share met expectations provided some support, while the company’s technological progress and continued wafer runs were viewed as positive tailwinds. Overall, the market’s response reflected a mix of concern over revenue and optimism about future product commercialization.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.